|
× |
 |
Agomelatine Prevents Relapse in Patients With Major Depressive Disorder Without Evidence of a Discontinuation Syndrome: A 24-Week Randomized, Double-Blind, Placebo-Controlled Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
Association of Bupropion, Naltrexone, and Opioid Agonist Treatment With Stimulant-Related Admissions Among People With Opioid Use Disorder: A Case-Crossover Analysis PDF |
$40.00 |
|
$40.00 |
|
× |
|
Disease Severity, Quality of Life, and Psychiatric Morbidity in Patients With Psoriasis With Reference to Sociodemographic, Lifestyle, and Clinical Variables: A Prospective, Cross-Sectional Study From Lahore, Pakistan PDF |
$40.00 |
|
$40.00 |
|
× |
|
Naltrexone in the Treatment of Dissociative Symptoms in Patients With Borderline Personality Disorder: An Open-Label Trial PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Use of Prescription Opioid Medication by Patients With Borderline Personality Disorder and Axis II Comparison Subjects: A 10-Year Follow-Up Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
Latent Trajectories of Trauma Symptoms and Resilience: The 3-Year Longitudinal Prospective USPER Study of Danish Veterans Deployed in Afghanistan PDF |
$40.00 |
|
$40.00 |
|
× |
|
Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 Report PDF |
$40.00 |
|
$40.00 |
|
× |
|
Randomized, Double-Blind Comparison of Sertraline and Placebo for Posttraumatic Stress Disorder in a Department of Veterans Affairs Setting PDF |
$40.00 |
|
$40.00 |
|
× |
|
Helping Families With End-of-Life Care in Alzheimer's Disease PDF |
$40.00 |
|
$40.00 |
|
|
